Author/Authors :
Smyth، نويسنده , , Mark J. and Stagg، نويسنده , , John، نويسنده ,
Abstract :
In this issue of Cancer Cell, Park et al. demonstrate that anti-erbB2 antibody primes adaptive immunity for increased tumor clearance and suggest that chemotherapy may in fact interfere with this process.
